It’s rare to get an inside look at the inner workings of any company’s R&D practices and culture. It is even more unusual when such transparency is provided by a pharmaceutical company, an industry that closely guards and protects its intellectual property. Scientists at AstraZeneca (AZN) have taken the unusual step of publishing a paper which describes the inner workings of its R&D organization. Entitled: “Lessons learned from the fate of AstraZeneca’s drug pipeline: a five-dimensional framework”, the paper is rich in detail, remarkable in its candor, and pretty damning of scientific management and oversight.
Hey, check out all the research scientist jobs. Post your resume today!
